Probiotic peanut oral immunotherapy versus oral immunotherapy and placebo in children with peanut allergy in Australia (PPOIT-003): a multicentre, randomised, phase 2b trial - Paxton Loke, Francesca Orsini, Adriana C. Lozinsky, Michael Gold, Michael D. O'Sullivan, Patrick Quinn, Melanie Lloyd, Sarah E. Ashley, Sigrid Pitkin, Christine Axelrad, Jessica R. Metcalfe, Ee Lyn Su, Dean Tey, Marnie N. Robinson, Katrina J. Allen - Dissemin

Dissemin is shutting down on January 1st, 2025

Language
Login

Published in

Elsevier, Lancet Child and Adolescent Health, 3(6), p. 171-184, 2022

DOI: 10.1016/s2352-4642(22)00006-2

Links

Tools

Export citation

Search in Google Scholar

Probiotic peanut oral immunotherapy versus oral immunotherapy and placebo in children with peanut allergy in Australia (PPOIT-003): a multicentre, randomised, phase 2b trial

Journal article published in 2022 by Paxton Loke, Francesca Orsini, Adriana C. Lozinsky, Michael Gold, Michael D. O'Sullivan, Patrick Quinn, Melanie Lloyd, Sarah E. Ashley, Sigrid Pitkin, Christine Axelrad, Jessica R. Metcalfe, Ee Lyn Su, Dean Tey, Marnie N. Robinson, Katrina J. Allen and other authors.

This paper was not found in any repository, but could be made available legally by the author.

This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle

Preprint: archiving allowed

Upload

Green circle

Postprint: archiving allowed

Upload

Red circle

Published version: archiving forbidden

Policy details

Data provided by

SHERPA/RoMEO